Regencell Bioscience Holdings

RGC

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-20.48M

EBITDA$-15.77M

EBIT$-18.78M

Pre-tax Income$-8.97M

Net Income$-18.78M

Cash Equivalent$2.61M

Total Debt$180.22K

Book Value$9.16M

Book Value Per Share0.70

Return on Equity (ROE)-52.31%

Return on Assets (ROA)-50.95%

Return on Invested Capital (ROI)-52.31%

Net Profit Marginundefined

Current Ratio42.68

Quick Ratio41.89

Long-Term Debt / Equitynull